Synthesis and Anti-cancer Activity of Some Novel 5-Azacytosine Nucleosides

Nucleosides, Nucleotides and Nucleic Acids

Volumn 22, Issue 12, 2003, Pages 2161-2170

  Tiwari, Kamal N ^a   Cappellacci, Loredana ^a   Montgomery, John A ^a   Secrist III, John A ^a  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

Author keywords

4 Thionucleoside; 5 Azacytosine; Anti cancer activity

Indexed keywords

1 O ACETYL 2 DEOXY 3,5 DI O TOLUOYL 4 THIO DEXTRO PENTOFURANOSE; 2 DEOXY 1,3,5 TRI O ACETYL 4 THIO LEVO PENTOFURANOSE; 2' DEOXY 4' THIO 5 AZACYTIDINE; 5 AZACYTOSINE NUCLEOSIDE; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; HUMAN CELL; IN VIVO STUDY;

ANTINEOPLASTIC AGENTS; AZACITIDINE; CARBOHYDRATE CONFORMATION; CELL LINE, TUMOR; CELL SURVIVAL; CYTIDINE; CYTOSINE; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PENTOSES; PYRIMIDINE NUCLEOSIDES; SULFUR COMPOUNDS;

EID: 0347481326     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-120026872     Document Type: Article

References (25)

1. Secrist, J.A., III; Parker, W.B.; Tiwari, K.N.; Messini, L.; Shaddix, S.C.; Rose, L.M.; Bennett, L.L., Jr.; Montgomery, J.A. The synthesis and biological activity of certain 4′-thio nucleosides. Nucleosides Nucleotides 1995, 14 (3-5), 675-686.
2. Secrist, J.A., III; Riggs, R.M.; Tiwari, K.N.; Montgomery, J.A. Synthesis and anti-HIV activity of 4′-thio-2′,3′ -dideoxynucleosides. J. Med. Chem. 1992, 35, 533-538.
3. Tiwari, K.N.; Montgomery, J.A.; Secrist, J.A., III. The synthesis and biological activity of 1-(2-deoxy-4-thio-α-L-threo pentofuranosyl) thymine. Nucleosides Nucleotides 1993, 12 (8), 841-846.
4. Secrist, J.A., III; Tiwari, K.N.; Shortnacy-Fowler, A.T.; Messini, L.; Riordan, J.M.; Montgomery, J.A. Synthesis and biologic activity of certain 4′-thio-D-arabinofuranosyl purine nucleosides. J. Med. Chem. 1998, 41, 3865-3871.
5. Tiwari, K.N.; Secrist, J.A., III; Montgomery, J.A. Synthesis and biological activity of 4′-thio nucleosides of 2-chloro adenine. Nucleosides Nucleotides 1994, 13, 1819-1828.
6. Tiwari, K.N.; Shortnacy-Fowler, A.T.; Cappellacci, L.; Parker, W.B.; Waud, W.R.; Montgomery, J.A.; Secrist, J.A., III. Synthesis of 4′-thio-β-D-arabinofuranosylcytosine (4-thio-ara-C) and comparison of its anticancer activity with that of ara-C. Nucleosides, Nucleotides & Nucleic Acids 2000, 19, 329-340.
7. Tiwari, K.N.; Shortnacy-Fowler, A.T.; Cappellacci, L.; Parker, W.B.; Waud, W.R.; Montgomery, J.A.; Secrist, J.A., III. Synthesis and structure activity relationship of 5-substituted-4′-thio-β -D-arabinofuranosylcytosines. Nucleosides, Nucleotides & Nucleic Acids 2000, 19, 2005-2017.
8. Parker, W.B.; Shaddix, S.C.; Rose, L.M.; Waud, W.R.; Shewach, D.S.; Tiwari, K.N.; Secrist, J.A., III. Metabolism of 4′-thio-β -D-arabinofuranosylcytosine in CEM cells. Biochem. Pharmacol. 2000, 60, 1925-1932; Someya, H.; Shaddix, S.C.; Tiwari, K.N.; Secrist, J.A., III. Phosphorylation of 4′-thio-β-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase. J. Pharmacol. Exp. Ther. 2003, 304, 1314-1322.
9. Parker, W.B.; Shaddix, S.C.; Rose, L.M.; Waud, W.R.; Shewach, D.S.; Tiwari, K.N.; Secrist, J.A., III. Metabolism of 4′-thio-β -D-arabinofuranosylcytosine in CEM cells. Biochem. Pharmacol. 2000, 60, 1925-1932; Someya, H.; Shaddix, S.C.; Tiwari, K.N.; Secrist, J.A., III. Phosphorylation of 4′-thio-β-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase. J. Pharmacol. Exp. Ther. 2003, 304, 1314-1322.
10. Momparler, R.L. Molecular, cellular and animal pharmacology of 5-aza-2′-deoxycytidine. Pharmac. Ther. 1985, 30, 287-299; Richel, D.J.; Colly, L.P.; Kluin-Nelemans, J.C.; Willemze, R. The antileukaemic activity of aza-2-deoxycytidine (aza-dC) in patients with relapsed and resistant leukaemia. Br. J. Cancer 1991, 64, 144-148.
11. Momparler, R.L. Molecular, cellular and animal pharmacology of 5-aza-2′-deoxycytidine. Pharmac. Ther. 1985, 30, 287-299; Richel, D.J.; Colly, L.P.; Kluin-Nelemans, J.C.; Willemze, R. The antileukaemic activity of aza-2-deoxycytidine (aza-dC) in patients with relapsed and resistant leukaemia. Br. J. Cancer 1991, 64, 144-148.
12. Momparler, R.L.; Samson, J.; Momparler, L.F.; Rivard, G.E. Cell cycle effects and cellular pharmacology of 5-aza-2′-deoxycytidine. Cancer Chemother. Pharmacol. 1984, 13, 191-194; Glover, A.B.; Leyland-Jones. Biochemistry of azacitidine: A review. Cancer Treatment Reports 1987, 71, 959-964; Veselý, J. Mode of action and effects of 5-azacytidine and of its derivatives in eukaryotic cells. Pharmac. Ther. 1985, 28, 227-235.
13. Momparler, R.L.; Samson, J.; Momparler, L.F.; Rivard, G.E. Cell cycle effects and cellular pharmacology of 5-aza-2′-deoxycytidine. Cancer Chemother. Pharmacol. 1984, 13, 191-194; Glover, A.B.; Leyland-Jones. Biochemistry of azacitidine: A review. Cancer Treatment Reports 1987, 71, 959-964; Veselý, J. Mode of action and effects of 5-azacytidine and of its derivatives in eukaryotic cells. Pharmac. Ther. 1985, 28, 227-235.
14. Momparler, R.L.; Samson, J.; Momparler, L.F.; Rivard, G.E. Cell cycle effects and cellular pharmacology of 5-aza-2′-deoxycytidine. Cancer Chemother. Pharmacol. 1984, 13, 191-194; Glover, A.B.; Leyland-Jones. Biochemistry of azacitidine: A review. Cancer Treatment Reports 1987, 71, 959-964; Veselý, J. Mode of action and effects of 5-azacytidine and of its derivatives in eukaryotic cells. Pharmac. Ther. 1985, 28, 227-235.
15. Beisler, J.A.; Abbasi, M.M.; Kelley, J.A.; Driscoll, J.S. Synthesis and antitumor activity of dihydro-5-azacytidine, a hydrolytically stable analogue of 5-azacytidine. J. Med. Chem. 1977, 20, 806-812.
16. Voytek, P.; Beisler, J.A.; Abbasi, M.M.; Wolpert-DeFilippes, M.K. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine. Cancer Research 1977, 37, 1956-1961.
17. Dalal, M.; Plowman, J.; Breitman, T.R.; Schuller, H.M.; del Campo, A.A.; Vistica, D.T.; Driscoll, J.S.; Cooney, D.A.; Johns, D.G. Arabinofuranosyl-5-azacytosine: Antitumor and cytotoxic properties. Cancer Res. 1986, 46, 831-838.
18. Secrist, J.A., III; Tiwari, K.N.; Riordan, J.M.; Montgomery, J.A. Synthesis and biological activity of 2′-deoxy-4′-thio pyrimidine nucleosides. J. Med. Chem. 1991, 34, 2361-2366.
19. ser-interferon with γ-interferon on human cell lines of various histogenesis. Cancer Res. 1986, 46, 483-488; Struck, R.F.; Schmid, S.M. ; Waud, W.R. Antitumor activity of halogen analogues of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide and trofosfamide. Cancer Chemother. Pharmacol. 1994, 34, 191-196; Waud, W.R.; Tiwari, A.; Schmid, S.M.; Shih, T.-W.; Strong, J.M.; Hartman, N.R.; O'Reilly, S.; Struck, R.F. 4-demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedine. Cancer Res. 1997, 57, 815-817.
20. ser-interferon with γ-interferon on human cell lines of various histogenesis. Cancer Res. 1986, 46, 483-488; Struck, R.F.; Schmid, S.M. ; Waud, W.R. Antitumor activity of halogen analogues of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide and trofosfamide. Cancer Chemother. Pharmacol. 1994, 34, 191-196; Waud, W.R.; Tiwari, A.; Schmid, S.M.; Shih, T.-W.; Strong, J.M.; Hartman, N.R.; O'Reilly, S.; Struck, R.F. 4-demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedine. Cancer Res. 1997, 57, 815-817.
21. ser-interferon with γ-interferon on human cell lines of various histogenesis. Cancer Res. 1986, 46, 483-488; Struck, R.F.; Schmid, S.M. ; Waud, W.R. Antitumor activity of halogen analogues of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide and trofosfamide. Cancer Chemother. Pharmacol. 1994, 34, 191-196; Waud, W.R.; Tiwari, A.; Schmid, S.M.; Shih, T.-W.; Strong, J.M.; Hartman, N.R.; O'Reilly, S.; Struck, R.F. 4-demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedine. Cancer Res. 1997, 57, 815-817.
22. ser-interferon with γ-interferon on human cell lines of various histogenesis. Cancer Res. 1986, 46, 483-488; Struck, R.F.; Schmid, S.M. ; Waud, W.R. Antitumor activity of halogen analogues of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide and trofosfamide. Cancer Chemother. Pharmacol. 1994, 34, 191-196; Waud, W.R.; Tiwari, A.; Schmid, S.M.; Shih, T.-W.; Strong, J.M.; Hartman, N.R.; O'Reilly, S.; Struck, R.F. 4-demethylpenclomedine, an antitumor-active, potentially nonneurotoxic metabolite of penclomedine. Cancer Res. 1997, 57, 815-817.
23. Plowman, J.; Dykes, D.J.; Hollingshead, M.; Simpson-Herren, L.; Alley, M.C. 6. Human tumor xenograft models in NCI drug development. In Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval; Teicher, B., Ed.; Humana Press, Inc.: Totowa, NJ; 101-125.
24. Waud, W.R.; Schmid, S.M.; Montgomery, J.A.; Secrist, J.A., III. Preclinical antitumor activity of 2-chloro-9-(2-fluoro-β -D-arabinofuranosyl)adenine (Cl-F-ARA-A). Nucleosides, Nucleotides & Nucleic Acids 2000, 19, 447-460.
25. Waud, W.R.; Gilbert, K.S.; Shepherd, R.V.; Montgomery, J.A.; Secrist, J.A., III. Preclinical antitumor activity of 4′-thio-β -D-arabinofuranosylcytosine (4′-thio-ara-C). Cancer Chemother. Pharmacol. 2003, 51, 422-426.